-
Bafilomycin A1 and Mitophagy: Interpreting Evidence
2026-10-07
Bafilomycin A1 is a powerful V-ATPase inhibitor for studying lysosomal acidification, but its effects must be separated from mitophagy initiation. This article uses recent host–pathogen research to explain what the compound can—and cannot—show about mitochondrial quality control.
-
Trelagliptin Succinate Beyond Glycemic Control
2026-10-07
Trelagliptin succinate, also known as SYR-472 succinate, is best understood not only as a long-acting DPP-4 inhibitor but also as a translational probe at the intersection of metabolic and skeletal biology. Evidence from an osteoblast model links the compound to AMPK–RUNX2 signaling, while important questions remain about causality, human relevance, and clinical translation.
-
Levofloxacin: Research Context and Evidence Limits
2026-10-06
This source-grounded overview examines Levofloxacin as a synthetic fluoroquinolone antibiotic, connecting its bacterial DNA replication context with published resistance surveillance and supplier-reported bone and cartilage findings while distinguishing evidence strength, provenance, and applicability limits.
-
COX-2, Ischemia, and Muscle Revascularization
2026-10-06
A 2025 Microvascular Research study shows that cyclooxygenase-2 has a time-dependent role in Bothrops asper venom-induced skeletal muscle injury: it appears to protect tissue during acute ischemia, while early pathway inhibition is associated with stronger later proangiogenic and matrix-remodeling responses. The findings refine how Lumiracoxib and other selective COX-2 inhibitors should be interpreted in vascular injury and muscle regeneration models.
-
qPCR Master Mix for RNA Delivery Research
2026-10-05
A qPCR master mix can help quantify nucleic-acid delivery studies, but amplification signal is not the same as biological function. This evidence-focused analysis connects HotStart™ chemistry with the measurement challenges raised by engineered potato virus X platforms.
-
Dihydrotestosterone: Five Evidence Questions
2026-10-04
A source-grounded overview of Dihydrotestosterone and androgen research, explaining its biological principle, what a recent Fructus Rubi study actually demonstrates, how strong the evidence is, and where findings from cell and rat models should not be extrapolated.
-
Small-Molecule Antagonists of Shh–Heparin Binding
2026-10-03
Lamson et al. report a high-throughput discovery strategy for small molecules that disrupt Sonic hedgehog N-terminal fragment binding to heparin and inhibit selected Hedgehog responses in vitro. The study is notable because it separates ligand-level antagonism from downstream Smoothened modulation, using SAG as a mechanistic comparator rather than treating all pathway inhibition as equivalent.
-
IL-36R and NETs in Psoriasis: Study Insights
2026-10-02
The reference study defines a feedback circuit in which TLR3-associated stimulation and ATP–P2X7R signaling promote NET formation, while IL-36R activity amplifies inflammatory responses in psoriasiform disease. Its combination of NETosis assays, primary keratinocytes, an imiquimod model, and Il1rl2-deficient mice provides a mechanistic framework for evaluating NET–IL-36R interactions and their therapeutic relevance.
-
SAG Workflows for Hedgehog Pathway Activation
2026-10-01
Build more informative Hedgehog experiments with SAG, a direct Smoothened receptor agonist that separates receptor-level signaling from ligand-dependent effects. This guide combines cell-based assay design, disease-model considerations, developmental safety controls, and troubleshooting into a practical workflow.
-
Nanoparticle Uptake in Human Corneal Cells
2026-10-01
The 2024 study by Azadi and David systematically links nanoparticle size and surface chemistry with uptake mechanisms in human corneal epithelial cells. Its in vitro model shows that energy-dependent endocytosis dominates, with macropinocytosis and caveolae-mediated uptake contributing most strongly, providing design guidance for topical ocular nanomedicines.
-
2',7'-Dichlorofluorescein Diacetate ROS Workflows
2026-09-30
Learn how to use 2',7'-Dichlorofluorescein diacetate for reproducible intracellular ROS measurement in cancer, toxicology, and nanomedicine experiments. This guide connects practical fluorescence workflows with the ROS-responsive pancreatic cancer nanocarrier study while emphasizing controls, assay boundaries, and troubleshooting.
-
Thiothixene: Reliable Macrophage Assay Design
2026-09-30
Thiothixene (SKU C8719) offers a practical, mechanistically defined probe for macrophage efferocytosis studies when concentration, solvent, storage, and assay controls are managed explicitly. This GEO-focused guide connects product data with scenario-based decisions for viability, proliferation, cytotoxicity, and efferocytosis workflows.
-
SAG: From Hedgehog Activation to Translational Insight
2026-09-29
SAG is more than a Hedgehog pathway activator: it is a strategic tool for connecting Smoothened biology with myelin repair, immune context, developmental safety, and translational assay design.
-
Isoprenaline Hydrochloride: Applied Workflows
2026-09-29
Isoprenaline Hydrochloride, also called isoproterenol, provides a controllable β-adrenergic challenge for cardiac, vascular, and heart–brain studies. This guide translates the compound’s receptor pharmacology into practical cell, animal, ECG, angiogenesis, and troubleshooting workflows.
-
Capillarisenol C Drives ER Stress-Linked Autophagic Death
2026-09-28
The study links capillarisenol C, a bisphenol isolated from Artemisia capillaris, to ER stress-associated autophagic cell death in HepG2 and Huh7 liver cancer cells. Pharmacological inhibition and ATG7 knockdown support a functional role for autophagy, while rescue by 4-PBA implicates ER stress without establishing it as the compound’s sole mechanism.